AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Profusa, a biotech company, has secured a $100 million equity line of credit from Ascent Partners Fund to initiate its
treasury strategy. The agreement, formalized through a securities purchase agreement, will see all net proceeds from the financing dedicated to purchasing Bitcoin, with the acquisition process set to commence this week.This strategic move positions
among a growing number of public companies that are adopting Bitcoin as a treasury reserve asset. The decision reflects a broader trend in the corporate world, where companies are increasingly recognizing the value of digital assets in capital preservation and hedging against inflationary risks.Profusa’s commitment to allocate 100% of the equity line to Bitcoin purchases signals a strong conviction in the digital asset’s long-term value. This approach mirrors the strategies of other corporate giants, such as
and , which have previously added Bitcoin to their balance sheets. By doing so, Profusa is not only diversifying its treasury holdings but also sending a clear message about its belief in Bitcoin’s resilience and potential for growth.The market will be closely monitoring Profusa’s Bitcoin acquisition phase, as this development could influence broader investor sentiment toward Bitcoin in 2025. The company’s move may act as a catalyst for more traditional companies to explore similar Bitcoin treasury strategies, further solidifying the digital asset’s role in the corporate financial landscape.

Quickly understand the history and background of various well-known coins

Dec.02 2025

Dec.02 2025

Dec.02 2025

Dec.02 2025

Dec.02 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet